ve303
Cell therapyexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Nov 28, 2017 (NCT04236778)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06237452 | Phase 3 | May 20, 2024 | Vedanta Biosciences, Inc. |
| NCT04899115 | Phase 2 | Aug 6, 2021 | American Association for the Study of Liver Diseases, American College of Gastroenterology, University of Michigan, Vedanta Biosciences, Inc. |
| NCT03788434 | Phase 2 | Feb 8, 2018 | Vedanta Biosciences, Inc. |
| NCT04236778 | Phase 1 | Nov 28, 2017 | Vedanta Biosciences, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vedanta Biosciences, Inc. | For profit | 4 | 3 | 3 | 2017 |
| American Association for the Study of Liver Diseases | Academic/Hospital | 1 | 0 | 1 | 2021 |
| American College of Gastroenterology | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2021 |
4 organizations
Page 1 / 1